Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL761379 | 0.82 | ALDH1A1 (0.56) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL17258671 | 0.77 | ALDH1A1 (0.69) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL1133044 | 0.76 | LMNA (0.51) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL5706368 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL306348 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL29443546 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL5630877 | 0.72 | BRD4 (0.48) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL17353090 | 0.72 | ALDH1A1 (0.46) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL15550676 | 0.71 | ALDH1A1 (0.49) | ALDH1A1CYP2D6CYP2C19SMN1; SMN2TSHR | |
| SCHEMBL21314513 | 0.71 | SLC22A12 (0.40) | ALDH1A1SMN1; SMN2KDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009016663-A1 | AMPHIPHILIC DEXTRIN CONJUGATES AND THEIR USE IN PHARMACEUTICAL FORMULATIONS AS COMPLEXING AGENTS FOR HYDROPHOBIC DRUGS TO IMPROVE THE AQUEOUS SOLUBILITY AND CONSEQUENTLY THE THERAPEUTIC EFFICACY OF THE COMPLEXED DRUGS | ISTITUTO GIANNINA GASLINI (IT) | 2009-02-05 | — | — | WO | claimed |
| WO-2005059005-A1 | MOISTURE CURABLE HIGH STRENGTH, FLEXIBLE RTV ORGANIC COPOLYMER COMPOSITIONS AND METHODS OF PREPARATION | HENKEL CORPORATION (US) | 2005-06-30 | — | — | WO | claimed |
| EP-3430013-A1 | CARBAPENEM COMPOUNDS | Orchid Pharma Limited (IN) | 2019-01-23 | — | — | EP | disclosed |
| WO-2017158616-A1 | CARBAPENEM COMPOUNDS | ORCHID PHARMA LTD. (IN) | 2017-09-21 | — | — | WO | disclosed |
| EP-3122347-A1 | CELASTROL AND DERIVATIVES FOR THE TREATMENT OF OBESITY | The Children's Medical Center Corporation (US) | 2017-02-01 | — | — | EP | disclosed |
| WO-2015148802-A1 | CELASTROL AND DERIVATIVES FOR THE TREATMENT OF OBESITY | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2015-10-01 | — | — | WO | disclosed |
| EP-2588465-A1 | SGC STIMULATORS | Ironwood Pharmaceuticals, Inc. (US) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012003405-A1 | SGC STIMULATORS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
| WO-2011104540-A1 | ONE STEP PROCESS FOR THE PREPARATION OF CAPECITABINE | GENERICS [UK] LIMITED (GB) | 2011-09-01 | — | — | WO | disclosed |
| EP-2238102-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | Lead Therapeutics, Inc. (US) | 2010-10-13 | — | — | EP | disclosed |
| WO-2009085562-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | LEAD THERAPEUTICS, INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| EP-0828710-A1 | PROCESS FOR THE PREPARATION OF (THIO-)CARBONIC/CARBAMIC ACID 2-PYRROLIDONYL-3-ESTERS, THIO ESTERS AND AMIDES | ZENECA LIMITED (GB) | 1998-03-18 | — | — | EP | disclosed |
| WO-1998002191-A2 | CATIONIC AMPHIPHILE COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORPORATION (US) | 1998-01-22 | — | — | WO | disclosed |
| WO-1996039132-A1 | N,N-DISULFONYLATED AMINOBENZENE CARBOXYLIC ACIDS AND THE USE THEREOF AS THROMBIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996037466-A1 | PROCESS FOR THE PREPARATION OF (THIO-)CARBONIC/CARBAMIC ACID 2-PYRROLIDONYL-3-ESTERS, THIO ESTERS AND AMIDES | ZENECA LIMITED (GB) | 1996-11-28 | — | — | WO | disclosed |
| EP-0638082-A1 | MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 1995-02-15 | — | — | EP | disclosed |
| EP-0638082-A4 | MACROCYCLIC IMMUNOMODULATORS. | ABBOTT LAB (US) | 1994-06-09 | — | — | EP | disclosed |
| EP-0590022-A1 | IMIDAZO 1,5-a]QUINOXALINES | PHARMACIA & UPJOHN COMPANY (US) | 1994-04-06 | — | — | EP | disclosed |
| WO-1993004680-A1 | MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 1993-03-18 | — | — | WO | disclosed |
| WO-1993004679-A1 | MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 1993-03-18 | — | — | WO | disclosed |